FDG-PET/CT for diagnosis of primary ovarian cancer

Kazuhiro Kitajima, Kayo Suzuki, Michio Senda, Masato Kita, Yuji Nakamoto, Yumiko Onishi, Tetsuo Maeda, Takeshi Yoshikawa, Yoshiharu Ohno, Kazuro Sugimura

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)


BACKGROUND AND AIM: To evaluate the diagnostic value of integrated F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) to discriminate malignant from benign ovarian tumors. METHODS: One hundred and eight women suspected of having ovarian cancer underwent preoperative FDG-PET/CT scans. FDG uptake was quantified by calculating the maximum standardized uptake value (SUVmax) of each tumor. The receiver operating characteristic curve was drawn to determine the optimal cut-off values of SUVmax that would best discriminate between benign and malignant tumors. Histopathologic results served as the reference standard. We assessed the association between SUVmax and with International Federation of Gynecology and Obsterics stage in borderline and malignant tumors, using one-factor analysis of variance and an unpaired t test with Bonferoni correction. RESULTS: The SUVmax of benign (n=26), borderline (n=12) and malignant (n=73) lesions was 2.00±1.02, 2.72±1.04, and 7.55±4.29, respectively. Although there were significant differences between benign and malignant, and borderline and malignant lesions (P<0.0001), there was no significant difference between benign and borderline lesions. Using an SUVmax cutoff of 2.55, the sensitivity, specificity and accuracy of FDG-PET/CT scanning to detect malignant or borderline tumors were 82.4, 76.9, and 81.1%, respectively. The SUVmax of stage I (n=35), stage II (n=8), stage III (n=34) and stage IV (n=8) was 3.59±2.32, 5.18±1.34, 8.72±2.69, and 15.05±3.77, respectively, and significant differences were observed between SUVmax values and the various International Federation of Gynecology and Obsterics stage (P<0.0001). CONCLUSION: FDG-PET/CT scanning has a high diagnostic value in differentiating between malignant and benign tumors, and a low diagnostic value in differentiating between borderline and benign tumors.

Original languageEnglish
Pages (from-to)549-553
Number of pages5
JournalNuclear medicine communications
Issue number7
Publication statusPublished - 07-2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'FDG-PET/CT for diagnosis of primary ovarian cancer'. Together they form a unique fingerprint.

Cite this